Antibiotic Development Must Focus On Improving Health Outcomes, Access To Medicine, MSF Access Campaign Head Says

BMJ Opinion: Els Torreele: The search for new antibiotics — market-based solutions are not the answer
Els Torreele, executive director of the MSF Access Campaign, discusses market-based research and development (R&D) business models for antibiotic development and calls for “[t]otally different strategies for developing and delivering effective new antibiotics … ones that rely on public responsibility instead of incentives for commercial markets. … The remedy for a deeply flawed innovation ecosystem resides in directing R&D towards improving patient health outcomes and collaboration towards affordable and sustainable access for people in need wherever they live. … We must find the courage to explore radical solutions beyond business as usual because medicines shouldn’t be a luxury” (7/11).

The KFF Daily Global Health Policy Report summarized news and information on global health policy from hundreds of sources, from May 2009 through December 2020. All summaries are archived and available via search.

The Henry J. Kaiser Family Foundation Headquarters: 185 Berry St., Suite 2000, San Francisco, CA 94107 | Phone 650-854-9400
Washington Offices and Barbara Jordan Conference Center: 1330 G Street, NW, Washington, DC 20005 | Phone 202-347-5270

www.kff.org | Email Alerts: kff.org/email | facebook.com/KaiserFamilyFoundation | twitter.com/kff

Filling the need for trusted information on national health issues, the Kaiser Family Foundation is a nonprofit organization based in San Francisco, California.